Revival of the identification of cytotoxic T-lymphocyte epitopes for immunological diagnosis, therapy and vaccine development (Q37844333)

24 August 2017

1 reference

title

Revival of the identification of cytotoxic T-lymphocyte epitopes for immunological diagnosis, therapy and vaccine development (English)

1 reference

24 August 2017

0 references

0 references

0 references

5

George F Gao

1 reference

24 August 2017

Shuguang Tan

3

0 references

author name string

Jun Liu

series ordinal

1

1 reference

24 August 2017

Shihong Zhang

series ordinal

2

1 reference

24 August 2017

Beiwen Zheng

series ordinal

4

1 reference

24 August 2017

publication date

17 February 2011

1 reference

Experimental Biology and Medicine

24 August 2017

published in

1 reference

24 August 2017

volume

236

1 reference

24 August 2017

issue

3

1 reference

24 August 2017

page(s)

253-267

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

24 August 2017

1 reference

MHC antigens in NK cell recognition and lysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

Conformational changes in MHC class I molecules. Antibody, T-cell receptor, and NK cell recognition in an HLA-B7 model system

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

Influenza and the challenge for immunology

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

Generation of a neutralization-resistant variant of HIV-1 is due to selection for a point mutation in the envelope gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

Variation of influenza A, B, and C viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

Understanding presentation of viral antigens to CD8+ T cells in vivo: the key to rational vaccine design

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

Immunological surveillance against altered self components by sensitised T lymphocytes in lymphocytes choriomeningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

Use of synthetic peptides of influenza nucleoprotein to define epitopes recognized by class I-restricted cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

Induction of multifunctional human immunodeficiency virus type 1 (HIV-1)-specific T cells capable of proliferation in healthy subjects by using a prime-boost regimen of DNA- and modified vaccinia virus Ankara-vectored vaccines expressing HIV-1 Gag c

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

The challenges of host and viral diversity in HIV vaccine design

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

HIV and SIV CTL escape: implications for vaccine design

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

T cell-based diagnosis of childhood tuberculosis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

Diagnosis of tuberculosis in South African children with a T-cell-based assay: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

More than one reason to rethink the use of peptides in vaccine design

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

Immunogenicity and safety of an HIV-1 lipopeptide vaccine in healthy adults: a phase 2 placebo-controlled ANRS trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

Producing nature's gene-chips: the generation of peptides for display by MHC class I molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

Structural immunology and crystallography help immunologists see the immune system in action: how T and NK cells touch their ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

Molecular interactions of coreceptor CD8 and MHC class I: the molecular basis for functional coordination with the T-cell receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

Autoreactive CD8 T cells associated with beta cell destruction in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

Epitope discovery in West Nile virus infection: Identification and immune recognition of viral epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

Celiac disease association with CD8+ T cell responses: identification of a novel gliadin-derived HLA-A2-restricted epitope.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

Identification of novel HLA-A2-restricted human immunodeficiency virus type 1-specific cytotoxic T-lymphocyte epitopes predicted by the HLA-A2 supertype peptide-binding motif

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

Identification of an HLA-A*0201-restricted CD8+ T-cell epitope SSp-1 of SARS-CoV spike protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

T-cell epitopes in severe acute respiratory syndrome (SARS) coronavirus spike protein elicit a specific T-cell immune response in patients who recover from SARS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

The Membrane Protein of Severe Acute Respiratory Syndrome Coronavirus Acts as a Dominant Immunogen Revealed by a Clustering Region of Novel Functionally and Structurally Defined Cytotoxic T‐Lymphocyte Epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

Identification of HLA-A24-binding peptides of Mycobacterium tuberculosis derived proteins with beta 2m linked HLA-A24 single chain expressing cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

Tetramer-assisted identification and characterization of epitopes recognized by HLA A*2402-restricted Epstein-Barr virus-specific CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

Reconstitution by MHC-restricted peptides of HLA-A2 heavy chain with beta 2-microglobulin, in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

First glimpse of the peptide presentation by rhesus macaque MHC class I: crystal structures of Mamu-A*01 complexed with two immunogenic SIV epitopes and insights into CTL escape

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

Identification and structural definition of H5-specific CTL epitopes restricted by HLA-A*0201 derived from the H5N1 subtype of influenza A viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

Establishment of a quantitative ELISA capable of determining peptide - MHC class I interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

Recognition of human proinsulin leader sequence by class I-restricted T-cells in HLA-A*0201 transgenic mice and in human type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

Phenotypic analysis of antigen-specific T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

Flow cytometric measurement of intracellular cytokines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

Influenza virus hemagglutinin-specific cytotoxic T cell response induced by polypeptide produced in Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

Generation of cytotoxic T lymphocytes in vitro. I. Response of normal and immune mouse spleen cells in mixed leukocyte cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

Conditions controlling the proliferation of haemopoietic stem cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

HLA-restricted epitope identification and detection of functional T cell responses by using MHC-peptide and costimulatory microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

High throughput functional microdissection of pathogen-specific T-cell immunity using antigen and lymphocyte arrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

An approach to the identification of T cell epitopes in the genomic era: application to Francisella tularensis

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

Direct phenotypic analysis of human MHC class I antigen presentation: visualization, quantitation, and in situ detection of human viral epitopes using peptide-specific, MHC-restricted human recombinant antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

Combining MHC tetramer and intracellular cytokine staining for CD8(+) T cells to reveal antigenic epitopes naturally presented on tumor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

SYFPEITHI: database for MHC ligands and peptide motifs

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

Efficient identification of HLA-A*2402-restricted cytomegalovirus-specific CD8(+) T-cell epitopes by a computer algorithm and an enzyme-linked immunospot assay.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

Peptide libraries for T cell epitope screening and characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

Identification of hexon-specific CD4 and CD8 T-cell epitopes for vaccine and immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

Epitope mapping of HSV-1 glycoprotein K (gK) reveals a T cell epitope located within the signal domain of gK

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

Preprocalcitonin signal peptide generates a cytotoxic T lymphocyte-defined tumor epitope processed by a proteasome-independent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

Identification of novel CTL epitopes of CMV-pp65 presented by a variety of HLA alleles

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

Identification of T cell epitopes by the use of rapidly generated mRNA fragments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

Design and use of conditional MHC class I ligands.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

Conditional MHC class I ligands and peptide exchange technology for the human MHC gene products HLA-A1, -A3, -A11, and -B7

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

Discovery of CD8+ T cell epitopes in Chlamydia trachomatis infection through use of caged class I MHC tetramers

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

A consensus epitope prediction approach identifies the breadth of murine T(CD8+)-cell responses to vaccinia virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

Identification of poxvirus CD8+ T cell determinants to enable rational design and characterization of smallpox vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

Structure of the human class I histocompatibility antigen, HLA-A2

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

HLA-A2-peptide complexes: refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

A novel HLA-A*3303-restricted minor histocompatibility antigen encoded by an unconventional open reading frame of human TMSB4Y gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

Analysis of three HLA-A*3303 binding peptide anchors using an HLA-A*3303 stabilization assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

Structures of HLA-A*1101 complexed with immunodominant nonamer and decamer HIV-1 epitopes clearly reveal the presence of a middle, secondary anchor residue

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

Structures of an MHC class I molecule from B21 chickens illustrate promiscuous peptide binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

Two different, highly exposed, bulged structures for an unusually long peptide bound to rat MHC class I RT1-Aa

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

Contemporary analysis of MHC-related immunodominance hierarchies in the CD8+ T cell response to influenza A viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

T-cell receptor bias and immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

Structural determinants of T-cell receptor bias in immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

Complete responses of relapsed lymphoma following genetic modification of tumor-antigen presenting cells and T-lymphocyte transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

Modification of the HER2/NEU-derived tumor antigen GP2 improves induction of GP2-reactive cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

Increased immunogenicity of an anchor-modified tumor-associated antigen is due to the enhanced stability of the peptide/MHC complex: implications for vaccine design

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

Modulation of cytokine patterns of human autoreactive T cell clones by a single amino acid substitution of their peptide ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

Annulling a dangerous liaison: vaccination strategies against AIDS and tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

Comparative genomics of BCG vaccines by whole-genome DNA microarray

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

Enhanced contact tracing and spatial tracking of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

Specific detection of tuberculosis infection: an interferon-gamma-based assay using new antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

Alteration of epitope recognition pattern in Ag85B and ESAT-6 has a profound influence on vaccine-induced protection against Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

Immunodominant tuberculosis CD8 antigens preferentially restricted by HLA-B

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

Human cytolytic and interferon gamma-secreting CD8+ T lymphocytes specific for Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

A novel DNA vaccine containing multiple TB-specific epitopes casted in a natural structure (ECANS) confers protective immunity against pulmonary mycobacterial challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

Characterization of a Mycobacterium tuberculosis peptide that is recognized by human CD4+ and CD8+ T cells in the context of multiple HLA alleles

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

Highly focused T cell responses in latent human pulmonary Mycobacterium tuberculosis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

Cytolytic CD8+ T cells recognizing CFP10 are recruited to the lung after Mycobacterium tuberculosis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

Cancer immunotherapy: moving beyond current vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

Immunogenicity and antitumor effects of vaccination with peptide vaccine+/-granulocyte-monocyte colony-stimulating factor and/or IFN-alpha2b in advanced metastatic melanoma: Eastern Cooperative Oncology Group Phase II Trial E1696.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

The first 1000 dendritic cell vaccinees.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

Cancer regression in patients with metastatic melanoma after the transfer of autologous antitumor lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

Cancer regression in patients after transfer of genetically engineered lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

CD8 T cell response and evolutionary pressure to HIV-1 cryptic epitopes derived from antisense transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

Selective escape from CD8+ T-cell responses represents a major driving force of human immunodeficiency virus type 1 (HIV-1) sequence diversity and reveals constraints on HIV-1 evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

Effects of thymic selection of the T-cell repertoire on HLA class I-associated control of HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

An HIV-1 clade C DNA prime, NYVAC boost vaccine regimen induces reliable, polyfunctional, and long-lasting T cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

Long-lasting humoral and cellular immune responses and mucosal dissemination after intramuscular DNA immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

T cell responses to whole SARS coronavirus in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

Immunological responses and long-term treatment interruption after human immunodeficiency virus type 1 (HIV-1) lipopeptide immunization of HIV-1-infected patients: the LIPTHERA study

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

T Cell Receptor Cross-reactivity Directed by Antigen-Dependent Tuning of Peptide-MHC Molecular Flexibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

Structural Basis for T Cell Alloreactivity among Three HLA-B14 and HLA-B27 Antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

Post-translational modifications of naturally processed MHC-binding epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

Phosphorylation-dependent interaction between antigenic peptides and MHC class I: a molecular basis for the presentation of transformed self

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

Phosphorylated self-peptides alter human leukocyte antigen class I-restricted antigen presentation and generate tumor-specific epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

SARS coronavirus nucleocapsid immunodominant T-cell epitope cluster is common to both exogenous recombinant and endogenous DNA-encoded immunogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

Evolutionarily conserved protein sequences of influenza a viruses, avian and human, as vaccine targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

Reverse ELISPOT assay for clonal analysis of cytokine production I. Enumeration of gamma-interferon-secreting cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

Human Th1 Cell Lines Recognize the Mycobacterium tuberculosis ESAT-6 Antigen and its Peptides in Association with Frequently Expressed HLA Class II Molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010278

21 January 2018

Identifiers

DOI

10.1258/EBM.2010.010278

1 reference

24 August 2017

1 reference